logo

Therapix Biosciences Ltd. (TRPX)



Trade TRPX now with
  Date
  Headline
7/1/2020 7:17:56 AM Therapix Biosciences Receives Notice Of Delisting And Injunction From Israeli Court
6/29/2020 9:20:13 AM Therapix Biosciences Plans $2.6 Mln In Private Placement
4/1/2020 9:30:23 AM Therapix Biosciences Reports Pricing Of $1.25 Mln Public Offering
3/19/2020 9:28:51 AM Therapix Biosciences Signs Securities Purchase Agreement
12/4/2019 8:48:58 AM Therapix Biosciences Prices Registered Direct Offering Of 1 Mln ADSs At $1.25/ADS
12/2/2019 9:41:57 AM Therapix Biosciences Says Progression Of Its RESPECTRUM Product Candidate Into Clinical Stage
11/13/2019 9:32:26 AM Therapix Announces Positive Results From Phase IIa Trial Of THX-110 For Obstructive Sleep Apnea Program
11/7/2019 5:04:40 PM Therapix Biosciences And Destiny Biosciences Mutually Agree To Discontinue Negotiations On Proposed Merger
10/15/2019 8:33:19 AM Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study For New Drug Candidate THX-210
7/31/2019 9:29:47 AM Therapix Biosciences Announces Canadian Product License Issuance For TheraPEA
7/5/2019 3:54:44 AM Therapix Biosciences Posts Q1 Net Loss Of $2.14 Mln
6/18/2019 9:32:12 AM Therapix : THX-110 Positively Affects Symptoms In Adult Subjects With Obstructive Sleep Apnea
3/28/2019 8:37:57 AM Therapix Biosciences Announces Pricing Of $2.25 Mln Registered Direct Offering
3/19/2019 6:31:39 AM Therapix Biosciences Appoints Ron Prosor As Executive Advisor
12/21/2018 8:33:46 AM Therapix Biosciences Terminates FSD Acquisition LoI